Results

Total Results: 1,027 records

Showing results for "drug".

981. Archived: Final Research Plan: Syphilis Infection in Nonpregnant Adults and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan95/syphilis-infection-in-nonpregnant-adults-and-adolescents-june-2016
     September 18, 2014 - Food and Drug Administration; FTA-ABS = fluorescent treponemal antibody absorption; MHA-TP = microhemagglutination

982. Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/9H5mgkBCjNQVZZ4pnkNo6B
     February 01, 2016 - We planned to use meta-analysis to pool the efficacy outcomes by drug (such as escitalopram trials) and … drug family (such as all SSRIs), but heterogeneity across studies limited the number of combinable interventions … Re- sults from the 2011 National Survey on Drug Use and Health: Mental Health Findings. … Antidepressant drug therapy and suicide in severely depressed children and adults: A case– control study … antidepressant*[TIAB] OR antidepressives[TIAB] OR (antidepressive agent*[TIAB]) OR (antidepressive drug

983. Archived: Hepatitis B in Pregnant Women: Screening, February 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-pregnant-women-screening-2004
     February 15, 2004 - HBV infection in the United States include diagnosis with a sexually transmitted disease, intravenous drug

984. Screening for Syphilis Infection in Pregnancy: Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/xw8Xj4Bts4yaj_ZaBjCuer
     May 01, 2009 - risk for syphilis infection include uninsured women, women living in pov- erty, sex workers, illicit drug … agglutination (TPPA ) • U ninsured w om en • W om en living in poverty • Sex w orkers • Illicit drug

985. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/sTjqbTas6gW5pzaATpeBDn
     January 01, 2013 - Food and Drug Administration (FDA)–approved indications for hormone therapy in postmenopausal women are … FDA, “bioidentical hormone replacement therapy” is a marketing term rather than a formally defined drug … women, and the safety and effectiveness of these products have not been evaluated through the FDA’s drug … Food and Drug Administration. Bio-Identicals: Sorting Myths From Facts. Silver Spring, MD: U.S. … Food and Drug Administration; 2008.

986. Recommendation: Thyroid Dysfunction: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/thyroid-dysfunction-screening
     March 24, 2015 - a single name brand of thyroid hormone in the United States, making it the most commonly prescribed drug … Food and Drug Administration until 2000.

987. Archived: Evidence Summary: High Blood Pressure in Adults, Children, and Adolescents: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/high-blood-pressure-adults-children-adolescents-screening-2003
     April 01, 2003 - Adverse Effects of Treatment of Hypertension Serious or life-threatening adverse drug reactions have … Additionally, treatment of adult hypertensive patients with drug therapy and possibly nonpharmacological … Clinical effectiveness of non-drug treatment for hypertension: a meta-analysis.

988. Archived: Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the U.S. Preventive Services Task Force: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/reducing-risk-for-mother-to-infant-transmission-of-hepatitis-c-virus-a-systematic-review-for-the-us-preventive-services-task-force/hepatitis-c-screening-2013
     November 15, 2012 - Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using … 1.1–35.9); adjusted for maternal demographic characteristics, HCV RNA level, history of intravenous drug … adjusted for maternal demographic characteristics, HCV RNA level, fetal monitoring, history of intravenous drug

989. Archived: Evidence Summary: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary28/cognitive-impairment-in-older-adults-screening-2014
     October 22, 2013 - Food and Drug Administration for Alzheimer disease ( k = 58) and caregiver interventions ( k = 59) … ); harms studies included all trials that were included for KQ 4, open-label extensions of included drug … Food and Drug Administration; HMG-CoA = 3-hydroxy-3-methylglutaryl coenzyme A; HRQL = health-related … of life; KQ = key question; MCI = mild cognitive impairment; NSAID = nonsteroidal anti-inflammatory drug … Generally consistent findings by drug class effect; estimation of frequency of adverse events may be

990. Archived: Thyroid Disease: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/thyroid-disease-screening-1996
     January 01, 1996 - Unusual complications of antithyroid drug therapy: four case reports and review of literature.

991. Archived: Family Violence: Screening and Interventions, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/family-violence-screening-interventions-1996
     January 01, 1996 - abusive relationships: financial dependence on an abusive partner, fear of retribution, alcohol or drug

992. Archived: Evidence Summary: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chronic-obstructive-pulmonary-disease-screening-2016
     April 05, 2016 - Few trials reported harms for any individual drug class. … For the treatment questions, the search included treatment efficacy literature for the following COPD drug … screening registries, and systematic reviews, supplemented with information reported by the US Food and Drug … Twenty studies of 14 distinct trials were identified for the 3 included drug classes and 1 combination … Unknown: single subanalysis identified for most drug classes and outcomes Most subanalyses limited

993. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/by8VJVre6h6BmadrGxaFMM
     April 01, 2016 - cardiovascular disease (CVD) events and the 2007 recommendation on aspirin and nonsteroidal anti- inflammatory drug … Nonsteroidal anti- inflammatory drug therapy combined with aspirin use increases the risk for serious … Food and Drug Administration recently denied a manufacturer's request to add primary pre- vention of … Food and Drug Administration. Citizen Petition Denial Re- sponse From FDA to Bayer Healthcare LLC. … Food and Drug Administration; 2014. Accessed at www.regulations.gov/#!

994. Screening for Obesity in Children and Adolescents: USPSTF Recommendations Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/PdBbRgWKPMbHfeQeHkM242
     February 01, 2010 - clinical practice, obesity, screening ABBREVIATIONS USPSTF—US Preventive Services Task Force FDA—Food and Drug … Sibutramine, a centrally acting appe- tite suppressant, has been approved by the US Food and Drug Administra

995. Archived: High Blood Pressure in Adults, Children, and Adolescents: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-blood-pressure-adults-children-adolescents-screening-2003
     April 01, 2003 - sufficiently bothersome to interfere with adherence to the medication regimen—are common, but serious adverse drug … Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological

996. Archived: Brief Evidence Summary: Peripheral Arterial Disease (PAD): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/peripheral-arterial-disease-pad-screening
     August 08, 2005 - Peripheral arterial disease: epidemiology and drug therapy.

997. Archived: Brief Evidence Summary: Peripheral Arterial Disease (PAD): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/brief-evidence-summary/peripheral-arterial-disease-pad-screening-2005
     August 08, 2005 - Peripheral arterial disease: epidemiology and drug therapy.

998. Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening
     June 26, 2018 - Eligible treatments included US Food and Drug Administration (FDA)–approved pharmacotherapy (specifically … [95% CI, 0.98-1.05]; I 2 = 0.0%; 13 RCTs [20,485 participants]) for any individual bisphosphonate drug … or race Fair KQ4b: Effectiveness of Pharmacotherapy by Subgroup Women 4 (varies by drug … Consistency unknown (single trial); precise No evidence of reporting bias Single trial for each drug … Abbreviations: BMD, bone mineral density; EPC, Evidence-based Practice Center; FDA, US Food and Drug

999. Archived: Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/comparative-effectiveness-of-antiviral-treatment-for-hepatitis-c-virus-infection-in-adults-a-systematic-review/hepatitis-c-screening-2013
     November 15, 2012 - Food and Drug Administration. … Approval of Victrelis (boceprevir) a direct acting antiviral drug (DAA) to treat hepatitis C virus (HCV … Food and Drug Administration. … Food and Drug Administration for boceprevir in antiviral-naive patients with cirrhosis at baseline. … Food and Drug Administration for telaprevir.

1000. Screening for Syphilis: A Brief Update (pdf file)
      www.uspreventiveservicestaskforce.org/USPSTF_Admin/Home/GetFile/1/996/syphilup/pdf
      July 01, 2004 - Penicillin G is the recommended drug for treatment of syphilis at all stages. … Harms include drug-related effects including anaphylaxis from penicillin allergy.